Pyros Pharmaceuticals

Pre-clinical

Durham, United StatesFounded 2017pyrospharma.com

Focuses on developing and commercializing innovative treatments for rare pediatric diseases.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $65M

Focuses on developing and commercializing innovative treatments for rare pediatric diseases.

Generic Drugs

Total raised:$65M

Series B$40MFrazier Healthcare PartnersJan 15, 2020

Series A$25MFrazier Healthcare PartnersJun 15, 2018